DOI: 10.26717/BJSTR.2017.01.000310
Corresponding author:
Alexander E Berezin, Senior Consultant of Therapeutic Unit, Internal Medicine Department, State Medical University of Zaporozhye, UkraineReceived: August 12, 2017; Published: August 29, 2017
To view the Full Article Peer-reviewed Article PDF
Heart failure (HF) a leading cause of premature death in patients with established cardiovascular (CV) disease. Although the global burden of HF is increasing, there is no evidence regarding promising results that improves long-term clinical outcomes especially for HF with preserved and mid-regional pump function. In this context, determination of the vulnerable populations at higher risk of HF development and progression is very promising. Endothelial dysfunction (ED) plays a central role in the manifestation of HF regardless its phenotypes. There is a large body of evidence regarding that the endothelial progenitor cells (EPCs) as a component of endogenous vascular repair system could be modified by several stimuli including epigenetic factors and thereby they are involved in the pathogenesis of ED. However, there is unclear whether EPC dysfunction is only whiteness of HF or it could be a factor of HF manifestation in vulnerable population. The short communication is depicted the uncertain role of EPC dysfunction in pathogenesis of HF.
|Abstract| |Introduction| |Conclusion| |References|